Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones
Globenewswire· 2026-01-09 13:30
Aims to Build on Positive 2025 Interim TN-201 Results in First Half of 2026 with Longer-Term Follow-Up Data for Cohorts 1 and 2 from MyPEAK™-1 Trial of Adults with MYBPC3-Associated HCM Expects to Report One-Year Cohort 1 Data and Early Cohort 2 Data from RIDGE™-1 Study of TN-401 for PKP2-Associated ARVC in First Half of 2026 Plans to Pursue Alignment on Regulatory Pathways for Lead Gene Therapy Programs in 2026 Raised $60 Million in 4Q25 to Support Runway Through mid-2027 SOUTH SAN FRANCISCO, Calif., Jan ...
SEALSQ and Kaynes SemiCon Reach Final Agreement to Develop a Sovereign Indian Post-Quantum Semiconductor Joint Venture in Alignment with MeitY
Globenewswire· 2026-01-09 13:30
Geneva, Switzerland, Jan. 09, 2026 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, and a subsidiary of WISeKey International Holding AG (Nasdaq: WKEY; SIX: WIHN) (“WISeKey”), today announced that it has reached a final, binding agreement with Kaynes SemiCon to establish SEALKAYNESQ Ltd, a Joint Venture (“JV”) in India. The JV is being formed with the obje ...
NANO Nuclear Energy Announces Dismissal of Federal Securities Lawsuit
Globenewswire· 2026-01-09 13:30
NANO Nuclear Energy Inc. NANO Nuclear Energy Announces Dismissal of Federal Securities Lawsuit. Dismissal of Federal Securities Class Action Lawsuit Follows Dismissal of Related Shareholder Derivative Lawsuit. Dismissal of Federal Securities Class Action Lawsuit Follows Dismissal of Related Shareholder Derivative Lawsuit New York, NY, Jan. 09, 2026 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear micro modular reactor (MMR) and tech ...
Liberty Star Minerals Publishes Letter to Shareholders from Board Chairman Pete O’Heeron
Globenewswire· 2026-01-09 13:30
文章核心观点 - 公司董事长在致股东信中总结了2025年的重大进展与战略成就 并对未来关键矿物、铜和黄金的需求前景表示乐观 强调公司通过技术突破、组织优化和政府合作 致力于巩固美国关键矿物供应链并提升股东价值 [1][5][6] 2025年主要成就总结 - **勘探技术突破**:在红岩峡谷金矿项目进行了广泛的槽道采样 发现了品位极高的金矿化验结果 高达107.5克/吨和60.0克/吨 并将已知矿化延伸了100英尺 同时识别出六个宽度超过2英尺的新碧玉岩透镜体 [3] - **成功完成3D激发极化(IP)测量**:2025年6月启动覆盖约10英亩、探测深度达500英尺的先进3D IP测量 10月获得超预期结果 通过高电阻率和与硫化物矿化相关的高IP值 高精度绘制了含金矿脉 该技术有助于量化矿脉厚度、走向和倾角 优化未来钻探计划 [3] - **董事会增强**:2025年12月任命Matt Westbrook为董事会成员 其拥有关键矿物开发、国家安全投资和美国政府合作方面的丰富背景 加强了公司与联邦国内资源安全优先事项的战略协同 [3] - **战略公司重组**:2025年11月宣布对采矿权主张进行重组 在Liberty Star Hay Mountain Holdings LLC下成立专注子公司:专注于多矿物铜矿权的Earp Ridge Mines LLC、专注于世界级黄金目标的Red Rock Mines LLC 以及新定义的American Strategic Minerals实体 该结构提升了运营清晰度、资产差异化和针对性合资机会 [3] - **政府倡导与互动**:基于在华盛顿特区与多位议员工作人员的会晤 推动了美国关键矿物需求的认知 最终促成国会议员在7月致关键内阁部长的信函 重点提及Hay Mountain项目并敦促联邦加快对亚利桑那州采矿计划的支持 [3] - **完成SAM注册**:2025年6月成功在联邦奖项管理系统注册 为获得联邦拨款和合同打开了大门 增强了公司参与政府保障战略矿物国内来源项目的资格 [3] 项目与资产概述 - **旗舰项目**:Hay Mountain项目 包含红岩峡谷金矿项目、Earp Ridge铜矿项目和新成立的American Strategic Minerals 位于以斑岩铜-金-钼系统闻名的地区 展现出巨大潜力 [1][6] - **资产定位**:公司资产组合中的关键矿物 包括用于电气化的铜、用于电子产品和储备的黄金 以及钼和稀土等相关元素 对于减少美国对外国供应商的依赖至关重要 [5] 行业前景与公司展望 - **需求驱动**:清洁能源转型、技术创新和地缘政治因素推动关键矿物、铜和黄金需求前景异常光明 全球铜需求预计到2050年将翻倍 黄金在经济不确定性中保持其避险资产地位 [5] - **公司计划**:2026年计划利用有利形势 推进针对性钻探、寻求战略合作伙伴关系并探索拨款机会 以进一步圈定资源并创造股东价值 同时预期通过简化的许可和激励措施获得持续的联邦支持 [5]
Perma-Fix Environmental Services Receives Expanded Permit for Richland Facility, Approximately Tripling Liquid Mixed Waste Processing Capacity
Globenewswire· 2026-01-09 13:30
Permit Renewal Increases Potential Throughput to Approximately 1.2 Million Gallons Annually and Strengthens Long-Term Strategic Positioning at Perma-Fix NorthwestATLANTA, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) today announced that it has received a final Dangerous Mixed Waste Permit Renewal for its Perma-Fix Northwest (PFNW) Mixed Waste Facility (MWF) located in Richland, Washington. The permit, issued by the Washington Department of Ecology ( ...
Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference
Globenewswire· 2026-01-09 13:05
Following Guidance from the European Medicines Agency’s (EMA) Scientific Advice Working Party (SAWP) Regarding Iopofosine I 131 for the Treatment of Waldenstrom’s Macroglobulinemia (WM), Expects to Submit for Conditional Marketing Approval in Europe in 3Q 2026 Plans to Present Final Results and Subset Analysis of WM Patients from the Phase 2 CLOVER WaM Clinical Study of Iopofosine I 131 Anticipates Dosing of First Patients in Phase 1b Study of CLR 125 for the Treatment of Triple Negative Breast Cancer in 1Q ...
GigaCloud Technology Inc to Participate in 28th Annual Needham Growth Conference
Globenewswire· 2026-01-09 13:05
EL MONTE, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced that Larry Wu, its Founder and Chief Executive Officer, will present at the 28th Annual Needham Growth Conference on Friday, January 16, 2026, at 2:15 p.m. ET/11:15 a.m. PT. The virtual presentation will be webcast at https://investors.gigacloudtech.com/ and will be available for replay ...
Cartesian Therapeutics Highlights Recent Progress and Outlines 2026 Outlook
Globenewswire· 2026-01-09 13:04
Enrollment on track in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis IND application for Descartes-08 in myositis accepted by FDA; seamless adaptive clinical trial offering potential opportunity for a single pivotal trial expected to commence in 1H26 Phase 1/2 pediatric trial of Descartes-08 in juvenile dermatomyositis initiated Cash resources expected to support planned operations, including completion of planned Phase 3 trial for Descartes-08 for myasthenia gravis, into mid-2027 FREDERICK, ...
Hurco Reports Fourth Quarter and Full Year Results for Fiscal Year 2025
Globenewswire· 2026-01-09 13:00
核心财务表现 - 2025财年第四季度净亏损304.1万美元或每股亏损0.47美元,上年同期净亏损144.2万美元或每股亏损0.23美元 [1] - 2025财年全年净亏损1511.7万美元或每股亏损2.34美元,上年同期净亏损1660.8万美元或每股亏损2.56美元 [1] - 2025财年第四季度销售和服务收入为4546.7万美元,同比下降823.5万美元或15% [2] - 2025财年全年销售和服务收入为1.78554亿美元,同比下降803万美元或4% [2] 分地区销售表现 - 美洲地区第四季度销售额1823.4万美元,同比下降22%,全年销售额6860.4万美元,同比下降5% [3][4] - 欧洲地区第四季度销售额2347.5万美元,同比下降8%,全年销售额9086.3万美元,同比下降4% [3][5] - 亚太地区第四季度销售额375.8万美元,同比下降25%,全年销售额1908.7万美元,同比下降1% [3][7] 订单情况 - 2025财年第四季度新订单总额为4650.9万美元,同比下降456.8万美元或9% [8] - 2025财年全年新订单总额为1.7129亿美元,同比下降2701.2万美元或14% [8] - 美洲地区第四季度订单2200.3万美元,同比增长4%,但全年订单6914.8万美元,同比下降10% [9] - 欧洲地区第四季度订单2083.9万美元,同比下降13%,全年订单8156.9万美元,同比下降18% [10] - 亚太地区第四季度订单366.7万美元,同比下降39%,全年订单2057.3万美元,同比下降6% [11] 盈利能力与成本 - 2025财年第四季度毛利润为774.9万美元,毛利率为17%,上年同期毛利润1218.6万美元,毛利率23% [12] - 2025财年全年毛利润为3298万美元,毛利率为18%,上年同期毛利润3774.3万美元,毛利率20% [12] - 毛利率下降主要由于立式铣床整体销量下降、产品组合从高性能5轴机床转向3轴机床以及2025财年下半年美国进口商品关税增加导致销售成本上升 [12][13] - 2025财年第四季度销售、一般及行政费用为1120.7万美元,占销售额25%,全年为4324.8万美元,占销售额24% [14] 现金流与资产负债表 - 截至2025年10月31日,现金及现金等价物为4871.3万美元,较上年同期的3333万美元增加约1500万美元 [16] - 截至2025年10月31日,营运资本为1.73055亿美元,较上年同期的1.80788亿美元有所下降 [16] - 营运资本下降主要受存货和应收账款净额减少以及应付账款和衍生负债增加驱动 [16] - 公司无总债务,股东权益为1.98787亿美元 [21] 管理层评论与业务展望 - 首席执行官表示,美国和德国两大市场在本财年最后一个季度实现了年内最强的订单和销售表现,下半年订单和销售较上半年增长约5% [3] - 公司通过有针对性的领导层过渡加强了美国和德国团队,新领导层拥有深厚的行业经验并专注于执行、客户参与和增长 [3] - 公司在持续投资创新技术的同时,实现了销售、一般及行政费用同比减少近300万美元 [3] - 管理层认为,凭借强劲的资产负债表、更强大的管理团队和支持长期增长的产品组合,公司已做好准备应对周期 [3] 业务与市场描述 - 公司是一家国际工业技术公司,向全球金属切削和金属成型行业销售三个品牌的计算机数控机床 [17] - 旗下Hurco和Milltronics品牌机床配备具有专有软件的交互式控制系统,Takumi品牌机床配备由第三方生产的工业控制系统 [17] - 公司还生产高价值机床部件和附件,并提供可与任何机床集成的自动化解决方案 [17] - 终端市场包括独立加工车间、大型企业中的小批量制造业务以及生产型制造商 [17] - 客户为航空航天、国防、医疗设备、能源、运输和计算机设备等行业制造精密零件、工具、模具 [17] - 制造业务位于台湾、意大利和美国,通过直销和间接销售队伍在美洲、欧洲和亚洲销售产品 [17]
Silicon Motion Announces Fourth Quarter 2025 Earnings Conference Call
Globenewswire· 2026-01-09 13:00
TAIPEI, Taiwan and MILPITAS, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Silicon Motion Technology Corporation (NasdaqGS: SIMO) (“Silicon Motion” or the “Company”), a global leader in NAND flash controllers for solid state storage devices, plans to release its fourth quarter 2025 financial results after the market closes on February 3, 2026 and will host a conference call on February 4 at 8:00 a.m. Eastern Time. Participants must pre-register using the link below to participate in the live call. CONFERENCE CA ...